Submitted by Anonymous (not verified) on 28 November 2025 - 8:45
Human medicines European public assessment report (EPAR): Byfavo, remimazolam, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Byfavo, remimazolam, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised